Edap Tms SA
NASDAQ:EDAP

Watchlist Manager
Edap Tms SA Logo
Edap Tms SA
NASDAQ:EDAP
Watchlist
Price: 2.47 USD -0.8% Market Closed
Market Cap: 91.6m USD
Have any thoughts about
Edap Tms SA?
Write Note

Edap Tms SA
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Edap Tms SA
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Edap Tms SA
NASDAQ:EDAP
Change in Working Capital
€520k
CAGR 3-Years
N/A
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Biomerieux SA
PAR:BIM
Change in Working Capital
-€339.5m
CAGR 3-Years
-33%
CAGR 5-Years
-30%
CAGR 10-Years
-68%
Carmat SA
PAR:ALCAR
Change in Working Capital
-€6.7m
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biosynex SA
PAR:ALBIO
Change in Working Capital
€17.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Visiomed Group SA
PAR:ALVMG
Change in Working Capital
-€55k
CAGR 3-Years
75%
CAGR 5-Years
N/A
CAGR 10-Years
21%
Amplitude Surgical SA
PAR:AMPLI
Change in Working Capital
-€8.9m
CAGR 3-Years
-31%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
No Stocks Found

Edap Tms SA
Glance View

Market Cap
91.2m USD
Industry
Health Care

EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.

EDAP Intrinsic Value
7.06 USD
Undervaluation 65%
Intrinsic Value
Price

See Also

What is Edap Tms SA's Change in Working Capital?
Change in Working Capital
520k EUR

Based on the financial report for Dec 31, 2023, Edap Tms SA's Change in Working Capital amounts to 520k EUR.

What is Edap Tms SA's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-4%

Over the last year, the Change in Working Capital growth was 0%.

Back to Top